Reuters: Health
AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.
U.S. FDA approves AstraZeneca's diabetes drug for treating heart failure risk
U.S. FDA approves AstraZeneca's diabetes drug for treating heart failure risk
Reuters: Health
AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.
Reuters: Health
AstraZeneca Plc said on Monday U.S. regulators approved its diabetes drug Farxiga to be used as a treatment to reduce the chances of hospitalization for heart failure in adults with type-2 diabetes and other cardiovascular risks.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment